On BioNTech's (BNTX) first-quarter 2024 earnings call, investors' focus is likely to be on the updates related to its pipeline development now that the pandemic is over.

Investors in BioNTech SE (Symbol: BNTX) saw new options begin trading today, for the June 2026 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is ...

Read about BioNTech SE ADR (BNTX:XNAS) stock and today's latest news and financial updates. BNTX - BioNTech SE ADR News | Morningstar Morningstar brands and products ...

Investors in BioNTech SE (Symbol: BNTX) saw new options begin trading this week, for the April 1st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BNTX ...

An expert panel of the EU drug regulator, the European Medicines Agency (EMA) on Friday recommended marketing authorizations ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. BioNTech SE Sponsored ADR (BNTX) is a stock that can certainly grab the attention of ...

BNTX reported a profit of €12.18 per diluted share in the fourth quarter of 2021, compared with a 4Q 2020 profit of €1.43 per diluted share. BioNTech’s net profit jumped from €15.2m in ...

Review the current BioNTech SE ADR (BNTX:XWBO) dividend yield and history to decide if BNTX is the best investment for you.

BioNTech (NASDAQ: BNTX), a leader in messenger RNA technology and Pfizer’s Covid-19 vaccine partner, has seen its stock decline by almost 9.4% over the last week (five trading days) and by about ...